Akers Biosciences, Inc. (Nasdaq: AKER) announces that the European Patent Office has issued a patent covering the Company's Breath Ketone ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE